The metabolism of inorganic arsenic oxides, gallium arsenide, and arsine: A toxicochemical review

Toxicology and Applied Pharmacology

Volumn 193, Issue 3, 2003, Pages 309-334

  Carter, Dean E ^a   Aposhian, H Vasken ^b   Gandolfi, A Jay ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b University of Arizona   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; ARSENIC ACID; ARSENIC ACID DERIVATIVE; ARSENIC TRIOXIDE; ARSINE; CARBON; DRINKING WATER; GALLIUM ARSENIDE; GLUTATHIONE; INDUSTRIAL CHEMICAL; METHYL GROUP; PHOSPHATE; THIOL GROUP;

BINDING AFFINITY; BLOOD; CARCINOGENESIS; CELL METABOLISM; CHEMICAL ANALYSIS; CHEMICAL BOND; CHEMICAL REACTION; COMPLEX FORMATION; DATA ANALYSIS; DECOMPOSITION; DISSOCIATION CONSTANT; ENVIRONMENT; ENVIRONMENTAL EXPOSURE; GENETIC ANALYSIS; HUMAN; IMMUNE RESPONSE; INDUSTRY; LETHALITY; LUNG INJURY; METABOLISM; METABOLITE; METHYLATION; NONHUMAN; ORGAN; OXIDATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PARAMETER; PROTEIN BINDING; REACTION ANALYSIS; REDUCTION; REVIEW; SOLUBILITY; SPECIES COMPARISON; TESTIS FUNCTION; TOXICITY; TRANSPORT KINETICS; URINE; WATER ANALYSIS;

EID: 0346848892     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.taap.2003.07.009     Document Type: Article

References (87)

1. Theshold limit values for chemical substances and physical agents biological exposure limits . 1998;American Conference of Government Industrial Hygienists, Cincinnati, OH.
2. Aposhian H.V., Aposhian M.M. Arsenic mobilization by DMPS. Chappell W.R., Abernathy C.O., Calderon R.L. Arsenic Exposure and Health Effects. 2001;397-406 Elsevier, Amsterdam.
3. Apostoli P., Alessio L., Romeo L., Buchet J.P., Leone R. Metabolism of arsenic after acute occupational arsine intoxication. J. Toxicol. Environ. Health. 52:1997;331-342.
4. Toxicological Profile for Arsenic, Hydrazines, Jet Fuels, Strontium and Trichloroethylene. 2000;U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry, Atlanta.
5. Toxicological Profile for Arsenic, Hydrazines, Jet Fuels, Strontium and Trichloroethylene. 2001;U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry, Atlanta.
6. Ayala-Fierro F., Barber D.S., Rael L.T., Carter D.E. In vitro tissue specificity for arsine and arsenite toxicity in the rat. Toxicol. Sci. 52:1999;122-129.
7. 1 cells as a model for renal toxicity caused by arsine exposure. J. Toxicol. Environ. Health. 60:2000;67-79.
8. Blair P.C., Thompson M.B., Bechtold M., Wilson R.E., Moorman M.P., Fowler B.A. Evidence for oxidative damage to red blood cells in mice induced by arsine. Toxicology. 63:1990;25-34.
9. 1 mice, Fischer rats and Syrian golden hamsters system organ studies and comparison of clinical indices of exposure . Fundam. Appl. Toxicol. 14:1990;776-787.
10. Buchet J.P., Apostoli P., Lison D. Arsenobetaine is not a major metabolite of arsine gas in the rat. Arch. Toxicol. 72:1998;706-710.
11. Burns L.A., Munson A.E. Gallium arsenide selectively inhibits T cell proliferation and alters expression of CD25 (IL-2R/p55). J. Pharmacol. Exp. Ther. 265:1993;178-186.
12. Burns L.A., Sikorski E.E., Saady J.J., Munson A.E. Evidence for arsenic as the immunosuppressive component of gallium arsenide. Toxicol. Appl. Pharmacol. 110:1991;157-169.
13. Carter D.E., Peraza M.A., Ayala-Fierro F., Casarez E., Barber D.S., Winski S.L. Arsenic metabolism after pulmonary exposure. Chappell W.R., Abernathy C.O., Calderon R.L. Arsenic Exposure and Health Effects. 1999;299-310 Elsevier, Amsterdam.
14. Cotton F.A., Wilkinson G. Advanced Inorganic Chemistry a Comprehensive Text . fourth ed. 1980;John Wiley & Sons, New York.
15. Delnomdedieu M., Basti M.M., Styblo M., Otvos J.D., Thomas D.J. Complexation of arsenic species in rabbit erythrocytes. Chem. Res. Toxicol. 7:1994;621-627.
16. Dixon H.B.F. The biochemical action of arsonic acids be specially as phosphate analogs. Adv. Inorg. Chem. 44:1997;191-227.
17. Fowler B.A., Weissberg J.B. Arsine poisoning. N. Engl. J. Med. 291:1974;1171-1174.
18. Ginsburg J.M. Renal mechanism for excretion and transformation of arsenic in the dog. Am. J. Physiol. 208:1965;832-840.
19. Goering P.L., Maronpot R.R., Fowler B.A. Effect of intratracheal gallium arsenide administration on delta-aminolevulinic acid dehydratase in rats relationship to urinary excretion of aminolevulinic acid . Toxicol. Appl. Pharmacol. 92:1988;179-193.
20. Goyer R.A., Clarkson T.W. Toxic effects of metals. Klaasenn C.D. Casarett and Doull's Toxicology. sixth ed. 2001;818-820 McGraw-Hill, New York.
21. Hartmann C.B., McCoy K.L. Gallium arsenide augments antigen processing by peritoneal macrophages for CD4+ helper T cell stimulation. Toxicol. Appl. Pharmacol. 141:1996;365-372.
22. Hatlelid K.M., Brailsford C., Carter D.E. An in vitro model for arsine toxicity using isolated red blood cells. Fundam. Appl. Toxicol. 25:1995;302-306.
23. Hatlelid K.M., Brailsford C., Carter D.E. Reactions of arsine with hemoglobin. J. Toxicol. Environ. Health. 47:1996;145-157.
24. Hatlelid K.M., Carter D.E. Reactive oxygen species do not cause arsine-induced hemoglobin damage. J. Toxicol. Environ. Health. 50:1997;463-474.
25. Healy S.M., Casarez E.A., Ayala-Fierro F., Aposhian H.V. Enzymatic methylation of arsenic compounds. V. Arsenite methyltransferase activity in tissues of mice. Toxicol. Appl. Pharmacol. 148:1998;65-70.
26. Healy S.M., Wildfang E., Zakharyan R.A., Aposhian H.V. Diversity of inorganic arsenic biotransformation. Biol. Trace Elem. Res. 68:1999;249-266.
27. Healy S.M., Zakharyan R.A., Aposhian H.V. Enzymatic methylation of arsenic compounds. IV. In vitro and in vivo deficiency of the methylation of arsenite and monomethylarsenic in the guinea pig. Mutat. Res. 386:1997;229-239.
28. Hertz-Picciotto I. Interactions between arsenic and other factors in relation to carcinogenicity. Chappell W.R., Abernathy C.O., Calderon R.L. Arsenic Exposure and Health Effects. 2001;173-180 Elsevier, Amsterdam.
29. Hong H.L., Fowler B.A., Boorman G.A. Hematopoietic effects in mice exposed to arsine gas. Toxicol. Appl. Pharmacol. 97:1988;173-182.
30. Huang R., Lee T. Cellular uptake of trivalent arsenite and pentavalent arsenate in KB cells culture in phosphate-free medium. Toxicol. Appl. Pharmacol. 136:1996;243-249.
31. Huang R.N., Lee T.C. Arsenite efflux is inhibited by verapamil, cyclosporin A, and GSH-depleting agents in arsenite-resistant Chinese hamster ovary cells. Toxicol. Appl. Pharmacol. 41:1996;17-22.
32. Huff J., Chan P., Nyska A. Is the human carcinogen arsenic carcinogenic to laboratory animals? Toxicol. Sci. 55:2000;17-23.
33. Hughes W., Levy G.A. The toxicity of arsine solutions for tissue slices. Biochem. J. 41:1947;8-11.
34. Kafalas J.A., Gatos H.C., Button M.J. Hydrolysis of A(III)B(V) compounds. J. Am. Chem. Soc. 79:1979;4260-4261.
35. Kirkpatrick D.S., Dale K.V., Catania J.M., Gandolfi A.J. Low-level arsenite causes accumulation of ubiquitinated proteins in rabbit renal cortical slices and HEK293 cells. Toxicol. Appl. Pharmacol. 186:2003;101-109.
36. Kitchin K.T. Recent advances in arsenic carcinogenesis modes of action, animal model systems and methylated arsenic metabolites . Toxicol. Appl. Pharmacol. 172:2001;249-261.
37. Klimecki W.T., Carter D.E. Arsine toxicity chemical and mechanistic implications . J. Toxicol. Environ. Health. 46:1995;399-409.
38. Landrigan P.J., Costello R.J., Stringer W.T. Occupational exposure to arsine an epidemiologic reappraisal of current standards . Scand. J. Work Environ. Health. 8:1982;169-177.
39. Lerman S., Clarkson T.W. The metabolism of arsenite and arsenate by the rat. Fundam. Appl. Toxicol. 3:1983;309-314.
40. Levvy G.A. A study of arsine poisoning. Q. J. Exp. Physiol. 34:1947;47-67.
41. Li Y., Carter D.E., Mash E.A. Synthesis of the mono-cysteine disulfide of meso-2,3-dimercaptosuccinic acid. Synth. Commun. 28:1998;2057-2062.
42. Luckey T.D., Venugopal B. Metal Toxicity in Mammals. Vol. 1, Physiological and Chemical Basis for Metal Toxicity. 1977;Plenum Press, New York.
43. Luckey T.D., Venugopal B. Metal Toxicity in Mammals. Vol. 2, Chemical Toxicity of Metals and Metalloids. 1977;Plenum Press, New York.
44. Lynn S., Gurr J.R., Lai H.T., Jan K.Y. NADH oxidase activation is involved in arsenite-induced oxidative DNA damage in human vascular smooth muscle cells. Circ. Res. 86:2000;514-519.
45. Maiorino R.M., Aposhian M.M., Xu Z., Li Y., Polt R.L., Aposhian H.V. Determination and metabolism of dithiol chelating agents. XV. The meso-2,3-dimercaptosuccinic acid-cysteine (1:2) mixed disulfide, a major urinary metabolite of DMSA in the human, increases the urinary excretion of lead in the rat. J. Pharmacol. Exp. Ther. 267:1993;1221-1226.
46. Marafante E., Vahter M., Envall J. The role of methylation in the detoxification of arsenate in the rabbit. Chem.-Biol. Interact. 56:1985;225-238.
47. Mass M.J., Tennant A., Roop B.C., Cullen W.R., Styblo M., Thomas D.J., Kligerman A.D. Methylated trivalent arsenic species are genotoxic. Chem. Res. Toxicol. 14:2001;355-361.
48. Misra U.K., Tripathi A.K., Pandey R., Bhargwa B. Acute phosphine poisoning following ingestion of aluminum phosphide. Hum. Toxicol. 7:1988;343-345.
49. Mitchell, Roger D, Ayala-Fierro, F., Carter, D.E., 2000. Systemic indicators of inorganic arsenic toxicity in four animal species. J. Toxicol. Environ. Health Part A, 59, 119-134.
50. Moore S.A., Moennich D.M.C., Gresser M.J. Synthesis and hydrolysis of ADP-arsenate by beef heart submitochondrial particles. J. Biol. Chem. 258:1983;6266-6271.
51. Morrissey R.E., Fowler B.A., Harris M.W., Moorman M.P., Jameson C.W., Schwetz B.A. Arsine absence of developmental toxicity in rats and mice . Fundam. Appl. Toxicol. 15:1990;350-356.
52. Morse K.M., Setterlind A.N. Arsine poisoning in the smelting and refining industry. Arch. Ind. Health. 2:1950;148-169.
53. Arsenic in Drinking Water. 1999;National Academy Press, Washington, DC.
54. Omura M., Hirata M., Tanaka A., Zhao M., Makita Y., Inoue N., Gotoh K., Ishinishi N. Testicular toxicity evaluation of arsenic-containing binary compound semiconductors, gallium arsenide and indium arsenide, in hamsters. Toxicol. Lett. 89:1996;123-129.
55. Omura M., Tanaka A., Hirata M., Zhao M., Makita Y., Inoue N., Gotoh K., Ishinishi N. Testicular toxicity of gallium arsenide, indium arsenide and arsenic oxide in rats by repetitive intratracheal instillation. Fundam. Appl. Toxicol. 32:1996;72-78.
56. Pernis B., Magistretti M. A study of the mechanism of acute hemolytic anemia from arsine. Med. Lav. 51:1960;37-41.
57. Peterson D.P., Bhattacharyya M.H. Hematological response to arsine exposure quantitation of exposure response in mice . Fundam. Appl. Toxicol. 5:1985;499-505.
58. III) is more toxic than arsenite in Chang human hepatocytes. Toxicol. Appl. Pharmacol. 163:2000;203-207.
59. III) and arsenite LD50 in hamsters and in vitro inhibition of pyruvate dehydrogenase . Chem. Res. Toxicol. 14:2001;651-656.
60. Pierson B., Van Wagenen S., Nebesny K.W., Fernando Q., Scott N., Carter D.E. Dissolution of crystalline gallium arsenide in aqueous solutions containing complexing agents. Am. Ind. Hyg. Assoc. J. 50:1989;455-459.
61. Radabaugh T.R., Sampayo-Reyes A., Zakharyan R.A., Aposhian H.V. Arsenate Reductase II. Purine nucleoside phosphorylase in the presence of dihydrolipoic acid is a route of reduction of arsenate to arsenite in mammalian systems. Chem. Res. Toxicol. 15:2002;692-698.
62. Rael L.T. The effect of arsine on the human erythrocyte membrane. M.S. Thesis. 1997;University of Arizona, Tucson, AZ.
63. Rael L.T., Ayala-Fierro F., Carter D.E. The effects of sulfur-, thiol-, and thiol inhibitor compounds on arsine-induced toxicity in the human erythrocyte membrane. Toxicol. Sci. 55:2000;468-477.
64. Rosenthal G.J., Fort M.M., Germolec D.R., Ackermann M.F., Blair P., Lamm K.R., Luster M.I. Effects of subchronic exposure to arsine on immune function and host resistance. Toxicologist. 8:1988;19.
65. Rosner M.H., Carter D.E. Metabolism and excretion of gallium arsenide and oxides by hamsters following intratracheal instillation. Fundam. Appl. Toxicol. 9:1987;730-737.
66. Samikkannu, T., Chien-Hung Chen, Ling-Huei Yih, Wang, A.S.S. Shu-Yu Lin, Tsen Chien Chen, Kun-Yan Jan., 2003. Reactive oxygen species are involved in arsenic trioxide inhibition of pyruvate dehydrogenase activity. Chem. Res. Toxicol. 16, 409-414.
67. Sampayo-Reyes A., Zakharyan R.A., Healy S.M., Aposhian H.V. Monomethylarsonic acid reductase and monomethylarsonous acid in hamster tissue. Chem. Res. Toxicol. 11:2000;1181-1186.
68. Scott N., Carter D.E., Fernando Q. Reaction of gallium arsenide with concentrated acids formation of arsine . Am. Ind. Hyg. Assoc.J. 50:1989;379-381.
69. Scott N., Hatlelid K.M., MacKenzie N.E., Carter D.E. Reactions of arsenic (III) and arsenic (V) species with glutathione. Chem. Res. Toxicol. 6:1993;102-106.
70. Sikorski E.E., McCay J.A., White K.L. Jr., Bradley S.G., Munson A.E. Immunotoxicity of the semiconductor gallium arsenide in female B6C3F1 mice. Fundam. Appl. Toxicol. 13:1989;843-858.
71. Smith K.R., Klei L.R., Barchowsky A. Arsenite stimulates plasma membrane NADPH oxidase in vascular endothelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 280:2001;L442-L449.
72. Snow E.T., Hu Y., Yan C.C., Chouchane S. Modulation of DNA repair and glutathione levels in human keratinocytes by micromolar arsenite. Chappell W.R., Abernathy C.O., Calderon R.L. Arsenic Exposure and Health Effects. 1999;243-250 Elsevier, Amsterdam.
73. Snow E.T., Schuliga M., Chouchane S., Hu Y. Sub-toxic arsenite induces a multi-component protective response against oxidative stress in human cells. Chappell W.R., Abernathy C.O., Calderon R.L. Arsenic Exposure and Health Effects. 2001;265-276 Elsevier, Amsterdam.
74. Styblo M., Del Razo L.M., Vega L., Germolec D.R., LeCluyse E.L., Hamilton G.A., Reed W., Wang C., Cullen W.R., Thomas D.J. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch. Toxicol. 74:2000;289-299.
75. Thomas D.J., Styblo M., Lin S. The cellular metabolism and systemic toxicity of arsenic. Toxicol. Appl. Pharmacol. 176:2001;127-144.
76. Vallee B.L., Ulmer D.D., Wacker W.E.C. Arsenic toxicology and biochemistry. AMA Arch. Intern. Med. 21:1960;56-75.
77. Van Wagenen S., Carter D.E., Raghab A.G., Fernando Quintus. Kinetic control of peak shapes in atomic absorption arsenic determinations by arsine generation. Anal. Chem. 59:1987;891-896.
78. Webb D.R., Carter D.E. An improved wet digestion procedure for the analysis of total arsenic in biological samples by direct hydride atomic absorption spectrophotometry. J. Anal. Toxicol. 8:1984;118-123.
79. Webb D.R., Sipes I.G., Carter D.E. In vitro solubility and in vivo toxicity of gallium arsenide. Toxicol. Appl. Pharmacol. 76:1984;96-104.
80. Webb D.R., Wilson S.E., Carter D.E. Pulmonary and systemic toxicity of respirable gallium arsenide particles intratracheally instilled into rats. J. Am. Ind. Hyg. Assoc. 48:1987;660-667.
81. Wildfang E., Raddabaugh T.R., Aposhian H.V. Enzymatic methylation of arsenic compounds. IX. Liver arsenite methyltransferase and arsenate reductase activities in primates. Toxicology. 168:2001;213-221.
82. Winski S.L., Barber D.S., Rael L.T., Carter D.E. Sequence of toxic events in arsine-induced hemolysis in vitro implications for the mechanism of toxicity in human erythrocytes . Fundam. Appl. Toxicol. 38:1997;123-128.
83. Winski S.L., Carter D.E. Interactions of rat red blood cell sulfhydryls with arsenate and arsenite. J. Toxicol. Environ. Health. 46:1995;379-397.
84. Winski S.L., Carter D.E. Arsenate toxicity in human erythrocytes characterization of morphologic changes and determination of the mechanism of damage . J. Toxicol. Environ. Health Part A. 53:1998;345-355.
85. Yamanaka K., Hasegawa A., Sawamura R., Okada S. Cellular response to oxidative damage in lung induced by the administration of dimethylarsinic acid, a major metabolite of inorganic arsenic, in mice. Toxicol. Appl. Pharmacol. 108:1991;205-213.
86. Yamanaka K., Okada S. Induction of lung-specific DNA damage by metabolically methylated arsenics via the production of free radicals. Environ. Health Perspect. 102:1994;37-40.
87. III is the substrate for MMA methyltransferase of rabbit liver and human hepatocytes. Toxicol. Appl. Pharmacol. 158:1999;9-15.